US Senate Finance Committee legislation to lower drug costs in Medicare and Medicaid could be amended before it reaches the Senate floor to include provisions requiring that Medicare D plans pass through rebates to offset beneficiary cost sharing at the point of sale, chairman Chuck Grassley, R-IA, said during a committee markup of the bill 25 July.
The legislation passed the committee in a 19-9 vote with no major amendments